Company profile
SEngine Precision Medicine company profile
SEngine Precision Medicine uses algorithms and 3D organoid technology to develop drugs with more efficacy. It empowers patients and oncologists with more informed treatment options. The company's technology simultaneously tests more than 200 cancer drugs against a patient's unique tumor organoid outside the body. The results decode the most effective and least toxic treatment options that DNA sequencing alone cannot reveal. Its proprietary platform leverages the aggregated, anonymized test results to develop new cancer-fighting drugs.
Business identity
- Website
- https://senginemedicine.com
- Contact email
- [email protected]
- Phone number
- (833) 736-4163
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2015-01-01, Year
Headquarters
- Headquarters
- Seattle, Washington, United States
- Postal code
- 98109
- Country code
- US
- Continent
- North America